| Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643) |
|---|
| 03/20/2003 | US20030055105 Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids |
| 03/20/2003 | US20030053967 Use of 3,4-dihydroxy-mandelic acid for protecting against oxidative damage caused by ultra-violet light |
| 03/20/2003 | CA2459760A1 Method for preparing unsaturated fatty hydroxy-acids and esters thereof, their use in pharmaceutical and/or cosmetic compositions |
| 03/19/2003 | EP1292563A2 Compounds useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity |
| 03/19/2003 | EP0912531B1 Polyoxyalkylene substituted and bridged benzophenone derivatives as uv absorbers |
| 03/19/2003 | CN1103332C Biphenyl-5-alkanoic acid derivative and is application |
| 03/19/2003 | CN1103331C Process for extracting pyruvic acid from fermented liquid of pyruvic acid and preparing sodium pyrouvate |
| 03/18/2003 | US6534679 From fermentation broth |
| 03/12/2003 | EP1289922A2 Method for isolating polymethyl alkanoic acids and for the disposal of the resulting wastes |
| 03/12/2003 | EP1289517A2 Pharmaceutical compositions comprising cannabidiol derivatives |
| 03/12/2003 | EP0672031B1 Catechol diethers as selective pde iv inhibitors |
| 03/12/2003 | CN1402703A Tri-substd. phenyl derivs. and analogues |
| 03/12/2003 | CN1401623A Process and apparatus for purifying raw lactic acid |
| 03/11/2003 | US6531599 Compounds having activity as inhibitors of cytochrome P450RAI |
| 03/11/2003 | US6531597 Reacting a halo substituted benzene with a ketone to form a hydroxyalkyl benzene that is carbonylated with a strong acid |
| 03/11/2003 | US6531143 α-hydroxy fatty acid derivatives and external compositions containing the same |
| 03/06/2003 | WO2003018551A1 New mandelic acid derivatives and their use as thrombin inhibitors |
| 03/06/2003 | WO2003018515A2 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 03/06/2003 | WO2003018480A1 Method for the preparation of lactic acid and calcium sulphate dihydrate |
| 03/06/2003 | WO2001090062A3 Method for the production of trifluoroethoxy-substituted benzoic acids |
| 03/06/2003 | US20030045571 Process and intermediates to prepare latanoprost |
| 03/06/2003 | US20030044824 Preincubation assay methods |
| 03/06/2003 | CA2449515A1 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 03/05/2003 | EP1173138B1 Cosmetic or pharmaceutical utilisation of nanoscalic metal soaps |
| 03/05/2003 | EP1026167B1 Tricyclic triazolobenzazepine derivatives, process for producing the same and antiallergic agents |
| 03/05/2003 | CN1102561C Method of resolving racemic mixtures |
| 03/04/2003 | US6528499 Ligands for metabotropic glutamate receptors and inhibitors of NAALADase |
| 03/04/2003 | US6528096 Carrier mixed with additives having lubricant properties for preparing powdery pharmaceutical compositions for inhalation |
| 03/04/2003 | CA1341424C Diketohexanoic acids and 2- and 3-diloweralkyl derivatives thereof |
| 02/27/2003 | WO2003016305A1 Crystals including a malic acid salt of n-[2-(diethylamino) ethyl]-5-[(5-fluoro-2-oxo-3h-indole-3-ylidene) methyl]-2, 4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof |
| 02/27/2003 | WO2003016270A2 Selective estrogen receptor modulators |
| 02/27/2003 | WO2003016254A1 Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient |
| 02/27/2003 | WO2002053517A3 Process for stereoselective synthesis of prostacyclin derivatives |
| 02/27/2003 | CA2457468A1 Carboxylic acid derivatives and pharmaceutical agent comprising the same as active ingredient |
| 02/26/2003 | EP1285908A1 Substituted phenylpropionic acid derivatives |
| 02/26/2003 | CN1399623A Purification of aqueous solutions of organic acids |
| 02/26/2003 | CN1399622A Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 02/25/2003 | US6525086 Compounds, their preparation and use |
| 02/20/2003 | WO2003014296A2 A group of novel anti-cancer compounds with specific structure |
| 02/20/2003 | WO2003013610A2 Surfactant compounds and uses thereof |
| 02/20/2003 | WO2002030882A9 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 02/20/2003 | WO2002030860A9 Ketone compounds and compositions for cholesterol management and related uses |
| 02/20/2003 | WO2002024623A3 Novel alkanoic acid derivatives |
| 02/20/2003 | CA2456144A1 A group of novel anti-cancer compounds with specific structure |
| 02/20/2003 | CA2456052A1 Surfactant compounds and uses thereof |
| 02/19/2003 | CN1398251A Process for prepn. of salts of L-carnitine and alkanoyl L-carnitine with mucic acid |
| 02/19/2003 | CN1101802C Process for preparing loxoprofen sodium |
| 02/18/2003 | US6521769 Chiral phosphines, transition metal complexes thereof and uses thereof in asymmetric reactions |
| 02/18/2003 | US6521664 Pesticidal activity of functionalized alkenes |
| 02/18/2003 | US6521633 Treating NIDDM with RXR agonists |
| 02/13/2003 | WO2003011842A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 02/13/2003 | WO2003011808A1 Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities |
| 02/13/2003 | WO2003011807A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 02/13/2003 | US20030032842 Novel arylpropyl aldehyde derivatives, processes for producing the same, and methods of using the same |
| 02/13/2003 | US20030032827 Lipoxin compounds and their use in treating cell proliferative disorders |
| 02/13/2003 | CA2753329A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 02/13/2003 | CA2452665A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 02/12/2003 | CN1396904A Novel compound, their preparation and use |
| 02/12/2003 | CN1396903A Novel compound, their preparation and use |
| 02/06/2003 | WO2002008165A3 Phenolic compounds, and polymers derived therefrom |
| 02/06/2003 | US20030027925 Use of a 2-substituted-1,3-dioxocycloalkyl linker group to couple saccharide groups of both the O-glycoside and N-glycoside type to a polymer support in a solid phase systhesis process |
| 02/06/2003 | US20030027847 Carboxyformylacetamide derivatives for treatment of AIDS or ARC |
| 02/06/2003 | US20030027840 Estrogen receptor modulators |
| 02/05/2003 | EP1082121A4 Hiv integrase inhibitors |
| 02/05/2003 | EP0993433B1 Method for producing calcium pyruvates |
| 02/05/2003 | CN1395555A Calcium dicarboxylate ethers, method of making same, and treatment of vascular disease and diabetes therewith |
| 02/05/2003 | CN1395551A Novel arylpropionaldehyde derivatives and production and use of the same |
| 02/05/2003 | CN1394846A Alpha-substituted benzene acetic acid its preparation and farm pesticide containing said compound |
| 02/05/2003 | CN1394845A Ethylene glycol antimony acetate and its preparation method |
| 02/05/2003 | CN1394844A Preparation method of L-calcium malate and its special neutralization reactor |
| 02/05/2003 | CN1100748C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substituted phenyl)-4-oxobutyric acids |
| 02/05/2003 | CN1100747C Dialkyl ethers containing terinal caroxy or tetrazole group |
| 02/04/2003 | US6515021 The compounds according to the invention have pronounced activity in the fields of cell differentiation and cell proliferation |
| 02/04/2003 | US6514507 Administering 10-Hydroxy-2-decenoic acid and derivatives for stimulating epidermal renewal and/or combating intrinsic aging of the skin |
| 01/30/2003 | WO2003008368A1 Process and intermediates to prepare latanoprost |
| 01/30/2003 | US20030023096 Useful as anti-hyperlipemia, for the prevention of abortion, for analgesics, as antidiarrheals, sleep inducer, diuretic, anti-diabetes, abortient, cathartics, antiulcer, anti-gastritis or antihypertensive etc. |
| 01/30/2003 | US20030022865 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 01/30/2003 | CA2453631A1 Process and intermediates to prepare latanoprost |
| 01/29/2003 | EP1278734A2 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore |
| 01/29/2003 | EP0832081B1 Bicyclic-aromatic compounds |
| 01/29/2003 | CN1394198A Method of synthesizing alpha-ketol unsaturated fatty acid |
| 01/29/2003 | CN1394139A Anticancer agents |
| 01/28/2003 | US6512139 Oxidation inhibitors in prostane derivatives |
| 01/23/2003 | WO2003006576A1 Intumescent carbon-forming antipyren, method of production and use thereof |
| 01/23/2003 | US20030018013 Cardiovascular disorders; antilipemic agents; Alzheimer's disease |
| 01/23/2003 | US20030017095 Reactor having a heat exchange medium circulation |
| 01/22/2003 | EP1277751A1 2- and 2,5-substituted phenylketo-enols |
| 01/22/2003 | EP1277749A1 2- and 2,5-substituted phenylketo enols |
| 01/22/2003 | EP1277735A1 2- and 2,5-substituted phenylketo-enols |
| 01/22/2003 | EP1277734A1 2- and 2,5-substituted phenylketo-enols |
| 01/22/2003 | EP1277733A1 2- and 2,5-substituted phenylketo-enols |
| 01/22/2003 | EP1000006B1 Improved process of preparation of linear aldehydes |
| 01/22/2003 | EP0937085B1 Magnesium (-)hydroxycitrate, method of preparation, applications, and compositions in particular pharmaceutical containing same |
| 01/16/2003 | WO2002074727B1 A process for the preparation of cyclic amino acids |
| 01/16/2003 | WO2002046129A3 Inhibitors of histone deacetylase |
| 01/16/2003 | WO2001060778A3 Aspirin-triggered lipid mediators |
| 01/15/2003 | EP1274680A1 Synthesis intermediate products for producing vitamin d derivatives |
| 01/14/2003 | US6506917 Ligands which are more selective for retinoid X receptor than is retinoic acid |
| 01/14/2003 | US6506799 Treating or preventing a cardiovascular disease in a patient, comprising administering to a patient in need of such treatment or prevention a therapeutically effective amount of 6-(6-hydroxy-5,5-dimethylhexyloxy)-2,2-dimethyl-hexan-1-ol and |
| 01/14/2003 | US6506757 Carboxylic acid derivatives and drugs containing the same as the active ingredient |